From: Risk assessment in precapillary pulmonary hypertension: a comparative analysis
Baseline (N = 130) Mean ± SD | Last follow-up (N = 87) Mean ± SD | p-value Baseline to 2018 | |
---|---|---|---|
Age years | 62 ± 15 | 67 ± 15 | |
Female no. (%) | 78 (60) | 55 (63) | |
BMI kg/m | 27 ± 6 | 26 ± 6 | 0.004 |
WHOFc I/II/III/IV no. (%) | 5/43/70/12 (4/33/54/9) | 21/30/33/3 (24/35/38/3) | < 0.001 |
SMWD m | 321 ± 132 | 358 ± 143 | 0.005 |
Blood and serum parameters | |||
NT-proBNP ng/L | 2631 ± 8747 | 1904 ± 7580 | 0.001 |
Haemoglobin g/L | 140 ± 23 | 135 ± 26 | 0.962 |
Transferrin saturation % | 22 ± 14 | 26 ± 29 | 0.448 |
Ferritin µg/L | 126 ± 150 | 99 ± 89 | 0.106 |
RDW % | 14.9 ± 1.9 | 14.9 ± 2.4 | 0.527 |
CRP mg/dL | 0.9 ± 1.6 | 0.9 ± 1.8 | 0.959 |
GFR mL/min/1.73 m2 | 78 ± 28 | 75 ± 28 | < 0.001 |
Creatinin mg/dL | 1.1 ± 0.6 | 1.2 ± 1.1 | 0.003 |
Pulmonary function and BGA | |||
DLCO % | 64 ± 23 | 65 ± 23 | < 0.001 |
KCO % | 82 ± 27 | 81 ± 27 | 0.002 |
paO2 mmHg | 69 ± 14 | 67 ± 13 | < 0.001 |
SO2% | 93 ± 5 | 93 ± 5 | 0.001 |
Echocardiography | |||
RAA cm2 | 22 ± 5 | 18 ± 7 | < 0.001 |
TAPSE mm | 18 ± 4 | 23 ± 5 | < 0.001 |
sPAP mmHg | 61 ± 21 | 48 ± 21 | < 0.001 |
Pericardial eff. no.(%) | 21 (16) | 5 (6) | 0.038 |